Alcide Corp said preliminaryexperimental results obtained using a formulation it hasdeveloped for the disinfection of blood platelets indicatefeasibility for the approach.    The company notes there have been recent increases inreports of transmission of microbial infections in recipientsof platelets, which are used in blood transfusions in patientsundergoing cancer therapy.    The company said related whole blood tests with baboonblood showed no significant loss of in vitro activities orsurvival.    The company said as a followup to the studies on thjebacterial disinfection of platelets, it is planning to evaluatethe system for the inactivation of several viruses in thepresence of platelets.  The viruses include Herpes SimplexVirus Type I, cytomegalovirus and Human Immunodeficiency Virus,which is responsible for AIDS. Reuter&#3;